Skip to main content
. 2020 Nov 6;197:44–47. doi: 10.1016/j.thromres.2020.10.035

Table 3.

Anticoagulants therapies at baseline.

Therapy Patients n (%)
Therapeutic anticoagulant 10 (15.1)
 Enoxaparin 100 UI/kg body weight bid 7 (10.6)
 Fondaparinux (based on body weight) 1 (1.5)
 Warfarin (based on INR) 1 (1.5)
 Rivaroxaban 20 mg 1 (1.5)
Prophylactic anticoagulant 55 (83.4)
 Enoxaparin 4000 UI/die 31 (47.0)
 Enoxaparin 6000 UI/die 4 (6.1)
 Fondaparinux 2.5 mg 18 (27.3)
 Fondaparinux 1.5 mg (based on creatinine level) 2 (3.0)
No anticoagulants 1 (1.5)